Skip to Main Content

We publish recommendations and resources, together with a host of other material for the benefit of our users.

SPS PGD template for the insertion of the Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception.
A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for July 2026.
SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.
SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (DMPA) subcutaneous (SC) injection for contraception.
SPS PGD template for the supply of combined hormonal transdermal patch for contraception.
SPS PGD template for the supply of combined hormonal vaginal ring for contraception.
SPS PGD template for the supply of a fluconazole 150mg capsule (single dose) for the treatment of vulvo-vaginal candidiasis.
SPS PGD template for intrapartum administration of benzylpenicillin sodium for prevention of early-onset Group B Streptococcus (GBS) neonatal infection
SPS PGD template for the supply of clotrimazole cream for treatment of vulvo-vaginal candidiasis/candidal balanoposthitis
SPS PGD template for the supply of clotrimazole pessaries for treatment of vulvo-vaginal candidiasis.
We outline the responsibilities of ICBs in England as commissioners of NHS services using PGDs, and link to resources that provide further support and advice.
An update around biosimilar and key generic medicines to support system planning and mobilisation.
Recordings and podcasts of case based discussions about structured medication reviews in problematic polypharmacy, each focussing on a different condition.
Expert pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with a progressive, life-limiting illness.
Whether a healthcare professional (HCP) can prepare and/or administer contrast media supplied by another HCP under a PGD will depend on a range of factors.
Informing and supporting decision making when considering the most appropriate legal mechanism for administering contrast media in imaging services.
Understanding where PGDs can and cannot be used for the supply and/or administration of P and GSL medicines helps ensure correct legal mechanisms in practice.
A series of short videos about quality assurance in aseptic services.
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
A report on the state of the pharmacy technical services workforce in the North of England
A checklist for audits and self-inspections for the holders of wholesale distribution authorisations